Literature DB >> 16419154

Mechanism of metastasis by membrane type 1-matrix metalloproteinase in hepatocellular carcinoma.

Ying-Chi Ip1, Siu-Tim Cheung, Ka-Ling Leung, Sheung-Tat Fan.   

Abstract

AIM: To investigate the precise role of membrane type 1-matrix metalloproteinase (MT1-MMP) in hepatocellular carcinoma (HCC) metastasis.
METHODS: Human HCC cells Hep3B with overexpression of MT1-MMP were established by stable transfection, and compared with control cells carrying the empty vector. Cells were examined in vivo for their differences in the metastatic ability of athymic nude mice, and analyzed in vitro for their differences in invasion ability by invasion chamber coated with Matrigel, adhesion towards collagen I and migration through culture chamber. Cell proliferation and apoptosis in adherent and suspension status were evaluated by MTT and flow cytometry analysis.
RESULTS: We found that overexpression of MT1-MMP could increase intrahepatic metastasis in nude mice with orthotopic implantation of HCC cells (incidence of 100% [MT1-MMP transfectants] vs 40% [vector control transfectants], P<0.05). MT1-MMP could also enhance cell invasion through Matrigel (107.7 vs 39.3 cells/field, P<0.001), adhesion towards matrix (0.30 vs 0.12 absorbance unit at 540 nm, P<0.001), cell migration (89.3 vs 39.0 cells/field, P<0.001), and cell proliferation (24.3 vs 40.5 h/doubling, P<0.001). We also observed that MT1-MMP supported cell survival (71.4% vs 23.9%, P<0.001) with reduced apoptosis (43.7% vs 51.0%, P<0.05) in an attachment-free environment.
CONCLUSION: MT1-MMP overexpression could enhance metastasis. In addition to its active role in matrix degradation during tumor invasion, MT1-MMP enhances tumor cell survival upon challenge of detachment, which is important during metastasis when cells enter the circulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16419154      PMCID: PMC4320329          DOI: 10.3748/wjg.v11.i40.6269

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  47 in total

1.  Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.

Authors:  Elena I Deryugina; Liliana Soroceanu; Alex Y Strongin
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

2.  Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase.

Authors:  Elena I Deryugina; Boris I Ratnikov; Tanya I Postnova; Dmitri V Rozanov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2001-11-27       Impact factor: 5.157

3.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

4.  Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.

Authors:  K Nabeshima; T Inoue; Y Shimao; Y Okada; Y Itoh; M Seiki; M Koono
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

5.  Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases.

Authors:  Nor Eddine Sounni; Christian Roghi; Vincent Chabottaux; Mathias Janssen; Carine Munaut; Erik Maquoi; Beatriz G Galvez; Christine Gilles; Francis Frankenne; Gillian Murphy; Jean-Michel Foidart; Agnès Noel
Journal:  J Biol Chem       Date:  2004-01-16       Impact factor: 5.157

6.  Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases.

Authors:  Takahisa Takino; Naohiko Koshikawa; Hisashi Miyamori; Motohiro Tanaka; Takuma Sasaki; Yasunori Okada; Motoharu Seiki; Hiroshi Sato
Journal:  Oncogene       Date:  2003-07-24       Impact factor: 9.867

7.  Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration.

Authors:  Takahisa Takino; Hisashi Miyamori; Yumi Watanabe; Katsuji Yoshioka; Motoharu Seiki; Hiroshi Sato
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

8.  Matrix metalloproteinases (MMPs) safeguard osteoblasts from apoptosis during transdifferentiation into osteocytes: MT1-MMP maintains osteocyte viability.

Authors:  M A Karsdal; T A Andersen; L Bonewald; C Christiansen
Journal:  DNA Cell Biol       Date:  2004-03       Impact factor: 3.311

9.  A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma.

Authors:  Y Ishii; Y Nakasato; S Kobayashi; Y Yamazaki; T Aoki
Journal:  J Exp Clin Cancer Res       Date:  2003-09

10.  Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function.

Authors:  Q Yu; B P Toole; I Stamenkovic
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

View more
  8 in total

1.  Gene expression in the efferent ducts, epididymis, and vas deferens during embryonic development of the mouse.

Authors:  Elizabeth M Snyder; Christopher L Small; Daniela Bomgardner; Bingfang Xu; Ryan Evanoff; Michael D Griswold; Barry T Hinton
Journal:  Dev Dyn       Date:  2010-09       Impact factor: 3.780

2.  Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma.

Authors:  Shu-Guang Li; Zai-Yuan Ye; Zhong-Sheng Zhao; Hou-Quan Tao; Yuan-Yu Wang; Chun-Yu Niu
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

3.  Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma.

Authors:  Maria V Barbolina; Brian P Adley; David L Kelly; Angela J Fought; Denise M Scholtens; Lonnie D Shea; M Sharon Stack
Journal:  Lab Invest       Date:  2008-03-24       Impact factor: 5.662

4.  Premalignant variations in extracellular matrix composition in chemically induced hepatocellular carcinoma in rats.

Authors:  Nabil M Abdel-Hamid
Journal:  J Membr Biol       Date:  2009-08-18       Impact factor: 1.843

5.  Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.

Authors:  Yi-Hsien Hsieh; Shu-Ching Hsieh; Chien-Hsing Lee; Shun-Fa Yang; Chun-Wen Cheng; Meng-Ju Tang; Chia-Liang Lin; Chu-Liang Lin; Ruey-Hwang Chou
Journal:  Oncotarget       Date:  2015-10-27

6.  DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.

Authors:  Binhui Xie; Weihao Lin; Junming Ye; Xiaonong Wang; Bing Zhang; Shiqiu Xiong; Heping Li; Guosheng Tan
Journal:  J Exp Clin Cancer Res       Date:  2015-09-11

7.  PROX1 is a transcriptional regulator of MMP14.

Authors:  Silvia Gramolelli; Jianpin Cheng; Ines Martinez-Corral; Markus Vähä-Koskela; Endrit Elbasani; Elisa Kaivanto; Ville Rantanen; Krista Tuohinto; Sampsa Hautaniemi; Mark Bower; Caj Haglund; Kari Alitalo; Taija Mäkinen; Tatiana V Petrova; Kaisa Lehti; Päivi M Ojala
Journal:  Sci Rep       Date:  2018-06-22       Impact factor: 4.379

Review 8.  Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases.

Authors:  Eline Geervliet; Ruchi Bansal
Journal:  Cells       Date:  2020-05-13       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.